Industry rejects call for transparency over use of strategy that can delay competition from generic medicines
Big Pharma fights patent disclosure demand from investors
Recent Posts
- Close Brothers plunges as short seller claims it understated UK car finance risks
- Iran earns oil windfall as US turns blind eye
- BBC seeks to have Donald Trump’s $10bn lawsuit thrown out
- Mandelson received more than £1.5mn for stake in collapsed advisory firm
- Why America’s shale patch is not celebrating $100 oil
